Why current quality control tools are insufficient for clinical NGS-based tests
Introduction Clinical diagnostics form an important part of disease prognosis and diagnosis. It affects about 70% of medical decisions (1). Any
From disruptive to standard – making next-generation sequencing reliable: an interview with Christophe Roos
There is still a wide gap from genomic research to real, efficient, and qualitative support for therapeutic decision making. Expert Review of
Euformatics Raises 350,000 EUR Seed Investment
Euformatics, a Finnish genomic data startup, today announced that it has closed a seed financing round of 350,000 euros by Tekes and angel
NHS Innovation Expo, Manchester
Euformatics exposes at stand 49 (Team Finland) at the NHS Innovation Expo in Manchester, September
Tübingen MedGen Summer School – Standardising NGS quality control
From Next-Generation Sequencing to Translational Medicine in Neurological Disease Research Identifying disease-causing genes represents a major
CSO Christophe Roos discusses clinical application of NGS in Medical Laboratory Observer
Next-generation sequencing, with other technologies, is enabling the emergence of nucleic acid -based testing in the clinical lab. The article in
Euformatics variant interpretation in a Monash University genetic and clinical set-up
Euformatics and BC Platforms are to deliver the Public Health Genomics Program at Monash University a system to develop and improve methods for